Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration.

Bond L, Bowen G, Mertens B, Denson K, Jordan K, Vidakovic B, Mitchell CS.

Behav Sci (Basel). 2020 Jan 10;10(1). pii: E33. doi: 10.3390/bs10010033.

2.

A Comprehensive Examination of Percutaneous Endoscopic Gastrostomy and Its Association with Amyotrophic Lateral Sclerosis Patient Outcomes.

Bond L, Ganguly P, Khamankar N, Mallet N, Bowen G, Green B, Mitchell CS.

Brain Sci. 2019 Sep 4;9(9). pii: E223. doi: 10.3390/brainsci9090223.

3.

A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy.

Bond L, Bernhardt K, Madria P, Sorrentino K, Scelsi H, Mitchell CS.

Front Neurosci. 2018 Jan 24;12:10. doi: 10.3389/fnins.2018.00010. eCollection 2018.

Supplemental Content

Loading ...
Support Center